Literature DB >> 19448429

From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response.

Marco A Calzado1, Laureano De La Vega, Eduardo Munoz, M Lienhard Schmitz.   

Abstract

Oxygen deprivation (hypoxia) triggers a complex network of signaling pathways that result in changed gene expression patterns in order to cope with this challenge. Recent work has identified the serine/threonine kinase HIPK2 as a novel regulatory protein participating in hypoxic gene regulation. HIPK2 can affect apical as well as downstream events during the hypoxic response. Under normoxic conditions, HIPK2-mediated phosphorylation of the ubiquitin E3 ligase Siah2 weakens mutual binding and destabilizes the phosphorylated E3 ligase. Low oxygen levels result in strongly increased HIPK2/Siah2 interactions that lead to efficient polyubiquitylation and proteasomal degradation of the kinase. At the apical level, the Siah2 inhibiting phosphorylations are lost, thus allowing Siah2-dependent proteolysis of dioxygenases which in turn allows for activation of transcription factor HIF. Downstream events of the hypoxic response are affected by the proteasomal elimination of HIPK2 from gene repressing complexes, an event that allows for full induction of gene expression. Thus HIPK2 can regulate a subset of HIF-dependent and -independent genes during the hypoxic response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448429     DOI: 10.4161/cc.8.11.8597

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress.

Authors:  Kiros Hailemariam; Kenta Iwasaki; Bo-Wen Huang; Kensuke Sakamoto; Yoshiaki Tsuji
Journal:  J Cell Sci       Date:  2010-10-27       Impact factor: 5.285

2.  Molecular perturbations restrict potential for liver repopulation of hepatocytes isolated from non-heart-beating donor rats.

Authors:  Yuta Enami; Brigid Joseph; Sriram Bandi; Juan Lin; Sanjeev Gupta
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

3.  Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival.

Authors:  Cristina Lanni; Lavinia Nardinocchi; Rosa Puca; Serena Stanga; Daniela Uberti; Maurizio Memo; Stefano Govoni; Gabriella D'Orazi; Marco Racchi
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

Review 4.  The chemosensitivity of testicular germ cell tumors.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2014-04-02       Impact factor: 6.730

5.  NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.

Authors:  Howard Donninger; Diego F Calvisi; Thibaut Barnoud; Jennifer Clark; M Lee Schmidt; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Biol       Date:  2015-03-16       Impact factor: 10.539

6.  HIPK2-T566 autophosphorylation diversely contributes to UV- and doxorubicin-induced HIPK2 activation.

Authors:  Alessandra Verdina; Giuliana Di Rocco; Ilaria Virdia; Laura Monteonofrio; Veronica Gatti; Eleonora Policicchio; Alessandro Bruselles; Marco Tartaglia; Silvia Soddu
Journal:  Oncotarget       Date:  2017-03-07

Review 7.  Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control.

Authors:  Walter Becker
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

8.  HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.

Authors:  Francesca Siepi; Veronica Gatti; Serena Camerini; Marco Crescenzi; Silvia Soddu
Journal:  Biochim Biophys Acta       Date:  2013-02-26

9.  HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation.

Authors:  F De Nicola; V Catena; C Rinaldo; T Bruno; S Iezzi; C Sorino; A Desantis; S Camerini; M Crescenzi; A Floridi; C Passananti; S Soddu; M Fanciulli
Journal:  Cell Death Dis       Date:  2014-09-11       Impact factor: 8.469

10.  Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy.

Authors:  Hyung Jung Oh; Mitsuo Kato; Supriya Deshpande; Erli Zhang; Sadhan Das; Linda Lanting; Mei Wang; Rama Natarajan
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.